Monthly Archives: January 2021

Laidlaw Venture Partners Portfolio Company Voltron Therapeutics, Inc. Names Anthony Zook, Former CEO of AstraZeneca North America, Executive Chairman.

2021-01-28T21:15:30-05:00

From globenewswire.com: Voltron Therapeutics, Inc. today announced that it has appointed life science veteran Anthony Zook Executive Chairman of its Board of Directors. As a global industry leader, Mr. Zook brings years of strategic experience to Voltron Therapeutics and is expected to be instrumental in the further development and eventual commercialization of its Self Assembling Read More...

Laidlaw Venture Partners Portfolio Company Voltron Therapeutics, Inc. Names Anthony Zook, Former CEO of AstraZeneca North America, Executive Chairman.2021-01-28T21:15:30-05:00

Laidlaw served as Sole Book-Runner on the $14,375,000 Offering for Evoke Pharma (EVOK)

2021-01-13T18:00:41-05:00

Laidlaw Capital Markets is pleased to have acted as the Sole Book-Runner on the $14,375,000 Follow-On Offering for Evoke Pharma (EVOK). Evoke has been a partner for years now and we are excited for their continued progress as a commercial stage company. https://evokepharmainc.gcs-web.com/news-releases/news-release-details/evoke-pharma-announces-pricing-public-offering-common-stock-0

Laidlaw served as Sole Book-Runner on the $14,375,000 Offering for Evoke Pharma (EVOK)2021-01-13T18:00:41-05:00
Site Info

Home
Contact Us
Company History

Legal

Terms and Conditions
Legal Information
Privacy Policy
Glossary
Record of Processing Activities
GDPR Rights Exercise Form

Disclosures

FINRA
SIPC
FCA
Business Continuity Plan Disclosure
Brokercheck
REGBI
StoneX Annual Disclosure
Options Disclosure Booklet

Contact Info

© 2024 Copyright Laidlaw & Company (UK) Ltd. – All Rights Reserved. Laidlaw & Company (UK) Ltd., a FINRA broker-dealer registered in the United States, clears on a fully-disclosed basis through StoneX, a member of the Securities Investor Protection Corporation (SIPC). Laidlaw & Company International Limited is authorized and regulated by the Financial Conduct Authority (FCA) in the UK (Firm Reference No: 537165).

© Copyright 2025 Laidlaw & Company (UK) Ltd. - All Rights Reserved. Laidlaw & Company (UK) Ltd., a FINRA broker-dealer registered in the United States, clears on a fully-disclosed basis through INTL FCStone Financial Inc., a member of the Securities Investor Protection Corporation (SIPC). Laidlaw & Company International Limited is authorized and regulated by the Financial Conduct Authority (FCA) in the UK (Firm Reference No: 537165).

You are now leaving Laidlaw & Company (UK) Ltd.

This link to the Private Stakes Program is provided as a service to Members, Clients and interested parties and will direct you to a third-party site independent of Laidlaw & Company (UK) Ltd.

Neither Laidlaw & Company (UK) Ltd. nor Laidlaw Private Equity, LLC own or manage the Private Stakes Program alternative investment vehicles. They are not responsible for the content of the site and do not guarantee the accuracy or completeness of any information or material contained therein.

Associated persons of Laidlaw & Company (UK) Ltd. and Laidlaw Private Equity, LLC are involved in the management and administration of each alternative investment vehicle described in the Private Stakes Program website.

Go to Top